Virtual Medicine Grand Rounds: Joseph Eron, MD and David Weber, MD, MPH, “COVID-19: Update on Epidemiology, Mitigation, Clinical Features, Treatment and Vaccines”

David Weber, MD has been on the faculty of the University of North Carolina at Chapel Hill since 1985 where he is currently the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Pediatrics and Epidemiology in the UNC School of Medicine, and UNC Gillings School of Global Public Health.  Dr. Weber serves as an Associate Chief Medical Officer for UNC.  He is the Secretary of the Board of the Society for Healthcare Epidemiology of America.  Dr. Weber has published more than 440 scientific papers in the peer-reviewed literature and more than 600 total papers and chapters.  His research interests include the epidemiology of healthcare-associated infections, disinfection and sterilization, new and emerging infectious diseases (novel influenza, SARS-coV, MERS-coV, Ebola, Candida auris), response to biothreats, nontuberculous mycobacteria, control of drug resistant pathogens, immunization practices (especially of healthcare personnel), zoonotic diseases, and epidemiology of tuberculosis.

Joseph J. Eron Jr., MD is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina at Chapel Hill.  He received his Infectious Diseases and HIV training at Massachusetts General Hospital under Drs. Martin Hirsch and Richard D’Aquila. He is the Principal Investigator of the HIV/AIDS Clinical Research Unit at UNC-CH and the Director of the Clinical Core for the UNC Center for AIDS Research (CFAR). He has been part of the AIDS Clinical Trials Group since 1993 and has held multiple leadership positions including Chair of the Optimization of ART (OpART) Committee and the Cure Transformative Science Group.  He is the Principal Investigator of the UNC Clinical trials Unit with sites in Chapel Hill, Greensboro, Lilongwe Malawi and Hanoi Vietnam. In addition he is a leader of the UNC Acute HIV Infection research team and is a collaborator in the UNC HIV Cure initiative. Over the last 10 years Dr. Eron has led the development of the UNC HIV CFAR Clinic Cohort that includes over 3500 HIV infected individuals and has active collaboration and membership in the NA ACCORD and CNICS cohorts. Dr. Eron has over 350 publications in peer-reviewed journals focusing on antiretroviral therapy, resistance, pharmacology, transmission and HIV persistence and disruption of latency.  Recent work has included publications from the UNC CFAR HIV Clinical Cohort, the AIDS Clinical Trials Group, HPTN 052 and IAS-USA HIV treatment guidelines in JAMA 2018.  Dr. Eron has worked extensively in the area of HIV drug development and led or participated in original studies of many antiretroviral therapies. He also continues as an active HIV and Infectious Disease clinician. He was awarded the HIVMA HIV Clinical Educator Award in 2013. He is now Vice Chief of the Division of Infectious Diseases and was recently elected Vice Chair of the AIDS Clinical Trials Group (ACTG).